☆ 4.8 Article

CD8+T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma

FRONTIERS IN IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies

Aurelie Beaufrere et al.

Summary: With the use of transcriptomic signature, we identified a 6-gene expression signature that is associated with microvascular invasion in hepatocellular carcinoma (HCC). This signature can be applied to routine tumor biopsies and is also associated with overall survival.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis

Antonio Giovanni Solimando et al.

Summary: A meta-analysis of second-line therapies for hepatocellular carcinoma (HCC) identified regorafenib and cabozantinib as potential treatment options, showing significant improvement in overall survival and progression-free survival compared with placebo in randomized controlled trials. None of the compared drugs stood out as clearly superior after stratification of patients.

CLINICAL AND EXPERIMENTAL MEDICINE (2022)

添加到收藏夹

Article Oncology

Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Roger Esteban-Fabro et al.

Summary: The combination of cabozantinib and anti-PD1 has shown enhanced antitumor immunity in the treatment of advanced hepatocellular carcinoma (HCC). The combination therapy increases immune cell infiltration, reduces regulatory T cell infiltration, and alters cell proportions in the blood. It is also associated with less aggressive tumor phenotypes in HCC patients.

CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Maria Reig et al.

Summary: There have been significant advances in the treatment strategies for hepatocellular carcinoma since the last update in 2018. However, some interventions still lack sufficient data for clinical incorporation, and personalized clinical management requires consideration of multiple parameters.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning

Jie-Yi Shi et al.

Summary: The study proposed a deep learning framework for analysing hepatocellular carcinoma (HCC) pathological images and exploring new prognostic phenotypes. Through TRS scoring and risk activation mapping, it effectively evaluated patient outcomes and identified the main underlying features of TRS. The results showed that TRS is an independent prognosticator superior to clinical staging systems.

GUT (2021)

添加到收藏夹

Article Medicine, Research & Experimental

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma

Zaoqu Liu et al.

Summary: The study identified three distinct tumor immunological microenvironment (TIME) phenotypes in hepatocellular carcinoma, each with different clinical outcomes, immune escape mechanisms, and genomic alterations. These findings may offer strategies to improve the efficacy of immunotherapy. Time index (TI) was proposed as a novel prognostic and immunotherapeutic signature to guide personalized immunotherapy and clinical management of HCC.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Single-Cell Transcriptome Analysis in Plants: Advances and Challenges

Rahul Shaw et al.

Summary: The adoption of single-cell RNA sequencing technology has revolutionized the transcriptome analysis, allowing for better understanding of tissue and cellular heterogeneity and rapid identification of rare cell types. In the field of plant sciences, single-cell transcriptome profiling is in its early stages and presents exciting challenges to overcome.

MOLECULAR PLANT (2021)

添加到收藏夹

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

添加到收藏夹

Article Oncology

Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management

Zaoqu Liu et al.

Summary: This study identified two hypoxia subtypes with distinct biological and clinical characteristics in hepatocellular carcinoma, enhancing the understanding of hypoxia pattern. Additionally, the developed and validated risk signature HARS showed excellent performance in predicting prognosis and immunotherapy.

JOURNAL OF ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Cell Biology

TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer

Zaoqu Liu et al.

Summary: A recent study revealed that CRC patients with TTN/OBSCN 'Double-Hit' phenotype had significantly better prognosis, an 'immune-hot' subtype, and potentially better immunotherapeutic efficacy.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Locoregional therapies, including local ablation and transarterial chemoembolization, play a crucial role in the management of hepatocellular carcinoma. Recent studies have shown potential benefits of combining these local therapies with systemic treatments, such as molecular therapies, to enhance therapeutic effects.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Article Immunology

CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma

Xiangkun Wu et al.

Summary: Through immunogenomic analysis, two distinct molecular clusters related to CD8(+) T cells were identified in ccRCC, each with different characteristics and prognoses. These findings provide new insights for evaluating the functions of CD8(+) T cells and hold significance for prognostic prediction and immunotherapeutic guidance for ccRCC patients.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Oncology

Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion

Er-lei Zhang et al.

Summary: The article evaluates the impact of current MVI status on surgical outcomes after curative therapies for HCC patients and emphasizes the urgent need for an international consensus on the validated definition of MVI in order to provide a more consistent evaluation and reliable prediction of surgical outcomes.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo

Huapan Fang et al.

Summary: While immunotherapy has shown promise as a cancer treatment, durable benefits are often limited by immune escape mechanisms. This study combines epigenetic regulation with gene therapy for immune checkpoint blockade to enhance anti-tumor effects and immune responses in vivo, providing a potential strategy for tumor treatment and prevention of relapse and metastasis.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Oncology

The immunological and metabolic landscape in primary and metastatic liver cancer

Xin Li et al.

Summary: This review discusses the unique immunological and metabolic features of the liver during cancer development, and how these factors can impact the development of primary liver cancer and liver metastases. The liver is often influenced by chronic inflammation and metabolic alterations, which may affect cancer metastasis.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Review Oncology

Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges

Shigao Huang et al.

CANCER LETTERS (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Advances in molecular classification and precision oncology in hepatocellular carcinoma

Sandra Rebouissou et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Tumour evolution in hepatocellular carcinoma

Amanda J. Craig et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes

Junyi Hu et al.

MOLECULAR THERAPY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Landscape and function of multiple mutations within individual oncogenes

Yuki Saito et al.

NATURE (2020)

添加到收藏夹

Review Oncology

Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology

Ye Wang et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice

Fang Wang et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma

Junyu Long et al.

EBIOMEDICINE (2019)

添加到收藏夹

Review Oncology

Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma

Lorenza Rimassa et al.

CANCER TREATMENT REVIEWS (2019)

添加到收藏夹

Article Oncology

Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data

Emily F. Davis-Marcisak et al.

CANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma

Marina Ruiz de Galarreta et al.

CANCER DISCOVERY (2019)

添加到收藏夹

Review Oncology

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma

Yaojie Fu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Editorial Material Oncology

Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC

Roser Pinyol et al.

CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Review Immunology

CTLA-4 (CD152): A versatile receptor for immune-based therapy

Holger Lingel et al.

SEMINARS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

Tathiane M. Malta et al.

CELL (2018)

添加到收藏夹

Review Immunology

Human T Cell Development, Localization, and Function throughout Life

Brahma V. Kumar et al.

IMMUNITY (2018)

添加到收藏夹

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Andrew Butler et al.

NATURE BIOTECHNOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

添加到收藏夹

Review Oncology

Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Maftools: efficient and comprehensive analysis of somatic variants in cancer

Anand Mayakonda et al.

GENOME RESEARCH (2018)

添加到收藏夹

Article Oncology

Liver cancer incidence and mortality in China: Temporal trends and projections to 2030

Rongshou Zheng et al.

CHINESE JOURNAL OF CANCER RESEARCH (2018)

添加到收藏夹

Article Medicine, Research & Experimental

IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade

Mark Ayers et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

添加到收藏夹

Article Biochemical Research Methods

Reversed graph embedding resolves complex single-cell trajectories

Xiaojie Qiu et al.

NATURE METHODS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

Claudio Isella et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Cell Biology

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong et al.

CELL REPORTS (2017)

添加到收藏夹

Review Oncology

Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy

Dae Won Kim et al.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)

Qiao Zhu et al.

BMC CANCER (2016)

添加到收藏夹

Review Multidisciplinary Sciences

T cell exclusion, immune privilege, and the tumor microenvironment

Johanna A. Joyce et al.

SCIENCE (2015)

添加到收藏夹

Article Oncology

Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma

Hsin-Jung Lee et al.

CARCINOGENESIS (2014)

添加到收藏夹

Article Multidisciplinary Sciences

pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels

Paul Geeleher et al.

PLOS ONE (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment

Yujin Hoshida

PLOS ONE (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

Allelic Imbalances and Homozygous Deletion on 8p23.2 for Stepwise Progression of Hepatocarcinogenesis

Yutaka Midorikawa et al.

HEPATOLOGY (2009)

添加到收藏夹

Article Biochemical Research Methods

WGCNA: an R package for weighted correlation network analysis

Peter Langfelder et al.

BMC BIOINFORMATICS (2008)

添加到收藏夹

Article Multidisciplinary Sciences

Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets

Yujin Hoshida et al.

PLOS ONE (2007)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Silhouette scores for assessment of SNP genotype clusters -: art. no. 35

L Lovmar et al.

BMC GENOMICS (2005)

添加到收藏夹

Article Multidisciplinary Sciences

Metagenes and molecular pattern discovery using matrix factorization

JP Brunet et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.